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Abstract
Background: Consistent asymmetry of the left-right (LR) axis is a crucial aspect of vertebrate embryogenesis.
Asymmetric gene expression of the TGFb superfamily member Nodal related 1 (Nr1) in the left lateral mesoderm
plate is a highly conserved step regulating the situs of the heart and viscera. In Xenopus, movement of maternal
serotonin (5HT) through gap-junctional paths at cleavage stages dictates asymmetry upstream of Nr1. However, the
mechanisms linking earlier biophysical asymmetries with this transcriptional control point are not known.
Results: To understand how an early physiological gradient is transduced into a late, stable pattern of Nr1
expression we investigated epigenetic regulation during LR patterning. Embryos injected with mRNA encoding a
dominant-negative of Histone Deacetylase (HDAC) lacked Nr1 expression and exhibited randomized sidedness of
the heart and viscera (heterotaxia) at stage 45. Timing analysis using pharmacological blockade of HDACs
implicated cleavage stages as the active period. Inhibition during these early stages was correlated with an
absence of Nr1 expression at stage 21, high levels of heterotaxia at stage 45, and the deposition of the epigenetic
marker H3K4me2 on the Nr1 gene. To link the epigenetic machinery to the 5HT signaling pathway, we performed
a high-throughput proteomic screen for novel cytoplasmic 5HT partners associated with the epigenetic machinery.
The data identified the known HDAC partner protein Mad3 as a 5HT-binding regulator. While Mad3 overexpression
led to an absence of Nr1 transcription and randomized the LR axis, a mutant form of Mad3 lacking 5HT binding
sites was not able to induce heterotaxia, showing that Mad3’s biological activity is dependent on 5HT binding.
Conclusion: HDAC activity is a new LR determinant controlling the epigenetic state of Nr1 from early
developmental stages. The HDAC binding partner Mad3 may be a new serotonin-dependent regulator of
asymmetry linking early physiological asymmetries to stable changes in gene expression during organogenesis.
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Background
Despite a bilaterally-symmetrical bodyplan, many animals
exhibit a consistent asymmetry in the placement and
shape of the heart, viscera, and brain [1]. The wide-spread
conservation of laterality, and the consistent linkage of the
orientation of the left-right (LR) axis with the dorso-ven-
tral and anterior-posterior axes (in a world that does not
distinguish left from right above the quantum level), make
LR patterning a fascinating problem [2-4]. In addition to
its relevance to basic cell, developmental, and evolutionary
biology, laterality presents significant implications for nor-
mal physiology and a plethora of clinically-important
human syndromes [5,6]. Errors in LR patterning include
loss of asymmetry (isomerism), complete inversions (situs
inversus), and random placement of individual organs
(loss of concordance known as heterotaxia).
It is widely accepted that large-scale LR asymmetry
derives from the molecular chirality of subcellular struc-
tures [7]. However, at least two main classes of models
have been proposed for how this chirality is propagated,
amplified, and imposed on multicellular fields during
development. One popular model focuses on the net
unidirectional extracellular fluid flow achieved during
gastrulation by the movement of cilia [8,9].
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A different model focuses on much earlier stages,
prior to gastrulation, when physiological events leverage
asymmetry from the chirality of the intracellular cytos-
keleton to set up asymmetrical movement of morpho-
gens through cell fields [10-12]. One such morphogen is
serotonin (5HT): a neurotransmitter of clinical relevance
that has interesting roles outside the central nervous
system [13]. In two vertebrate species (chick and frog),
serotonergic signaling has been shown to be required
for LR patterning. In the frog embryo, it is known that
5HT accumulates in the right blastomeres in a rapid
process dependent on asymmetric voltage gradients
across the midline and the presence of open gap junc-
tions through which it traverses [14-16].
In Xenopus embryos, many aspects of this system have
been elucidated: the source of the electrophoretic force
driving this 5HT gradient has been molecularly charac-
terized [14,17,18], and indeed many aspects are known
in enough quantitative detail to allow the whole system
to be computationally modeled [19,20]. However, one
fundamental question has not been addressed: how does
this physiological gradient, occurring in the frog at a
time when the zygotic genome is mostly quiescent, cou-
ple to the later transcriptional cascade of asymmetrically
expressed genes that is known to control organ posi-
tioning? Specifically: how does the arrival of 5HT within
the right-side blastomeres control gene expression?
Well-known 5HT receptor families [21] are not ideal
candidates because they are functional on the outside
surface of the plasma membrane, while the 5HT arrives
through gap junctions, and thus requires an intracellular
binding target.
To better understand how intracellular 5HT signaling
is transduced into stable gene expression, from early to
very late developmental stages, we hypothesized the
involvement of epigenetic machinery as a new compo-
nent of the LR establishment. Such a mechanism is
attractive because once epigenetic markers are deposited
on the chromatin, they remain stable along successive
cell divisions carrying the epigenetic signature of an
activated or repressed state of the chromatin. More spe-
cifically, we sought to determine whether early manipu-
lation of the epigenetic state of the embryo would affect
LR-relevant genes expressed at late developmental stages
(e.g., Nr1).
Changes in the state of the chromatin have a key role
for the proper control of gene expression during devel-
opment. Post-translational modifications such as lysine
acetylation constitute a code allowing specific interac-
tions between chromatin and DNA binding proteins
that ultimately will dictate the status of activation of a
gene [22]. These modifications take place at the chro-
matin level and involve the acetylation of lysines in the
amino terminal tail of core histones [23].
HDACs are important players for epigenetic memory
control as they act by decreasing the levels of acetylated
histones leading to chromatin compaction and repres-
sion [24,25]. HDACs play a critical role in regulating
gene expression and aberrant levels of protein acetyla-
tion have been associated with cancer [26] and a range
of neurological diseases such as fragile X mental retar-
dation [27]. Indeed, HDACs blockers can reverse silent
heterochromatin to an active conformational structure
leading to the normal function of genes that are silent
in these pathologies [27]. Despite their prominent role
on gene expression, HDACs can not bind to the DNA
on their own, but are recruited to specific points on the
chromatin via interaction with transcriptional repressive
complexes such as those containing Mad proteins [28].
Vertebrate HDACs can be classified into four groups:
Class I (HDAC 1,2,3,8), Class IIa (HDAC 4,5,7,9) Class
IIb (HDAC 6) and Class IV (HDAC 10,11). Xenopus has
a maternal form of HDAC (HDAC) that shows sequence
homology to other HDAC [29]. The HDAC activity in
early embryos appears to be mainly, if not exclusively, of
the HDAC-A type, that is of the vertebrate HDAC I class
[30]. Although HDAC function during Xenopus develop-
ment remains unclear, several studies have demonstrated
its importance for vertebrate development. Genetic dele-
tion of HDACs in mice and embryonic stem cells results
in problems in proliferation [31,32], while the deletion of
hdac1 in zebrafish leads to defects in skeletal and neuro-
nal development [33,34]. Interestingly, in HDAC-null ES
cells, only 3% of genes are downregulated and about 5%
are upregulated. This suggests that the epigenetic
machinery is directed to specific points of the chromatin,
and indicates that HDACs could underlie regulation of
specific developmental signals [35].
Here, we probe the involvement of HDACs in LR
asymmetry establishment. Using several molecular and
pharmacological tools, we found that HDAC activity is a
new component of LR patterning that acts very early in
embryonic development (prior to active zygotic tran-
scription). In addition, we identified the HDAC-interact-
ing protein Mad3 as a new component during LR
development in the 5HT signaling pathway. Our results
demonstrate how very early physiological signaling can
be transduced into a stable pattern of gene expression at
late developmental stages, and sheds light on how epige-
netic state and chromatin structure orchestrate impor-




Plasmids containing X. laevis Mad3 and X. laevis mater-
nal HDAC cDNA were purchased from Open Biosys-
tems (Clone ID: 4175511 and Clone ID: 6862376,
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respectively) and the DN HDAC was generated by PCR
as described [36]. pCS2Vp16 and pCS2Eng were pro-
vided by Dr. D. Kessler and the constructs pCS2Eng-
Mad3 and pCS2Vp16Mad3 were generated by PCR
cloning. To induce ectopic expression of Xenopus Mad3
and HDAC, their coding regions were inserted into the
pCS2-flag expression vector, resulting in the addition of
the flag-tag to the N-terminus of the coding region of
Mad3. Mad3 and HDAC pCS2 plasmids were linearized
with NotI to prepare for transcription with the SP6
Message machine kit (Ambion). Mad3-5 mut (Gln125
and Gln161 were replaced by glutamate; Asp145,
Asp148 and Asp163 were replaced by asparagine) was
generated by PCR mutagenesis with an Agilent kit.
Xenopus embryos microinjection
For microinjections, capped, synthetic mRNAs [37], gener-
ated using the Ambion mMessage mMachine kit were dis-
solved in water plus the lineage tracer rhodamine-labeled
dextran (RLD) and injected into embryos in 3% Ficoll. 30
minutes post-injection, embryos were transferred to 0.1X
MMR and allowed to develop until stage 21 for in situ
hybridization or stage 45 for organ placement score. All
experimental procedures involving the use of animals for
experimental purposes were approved by the Institutional
Animal Care and Use Committees (IACUC) and Tufts
University Department of Lab Animal Medicine (DLAM)
under the protocol number M2008-08.
Scoring for Organ situs
At stage 45, embryos were anesthetized with 5% tricaine
and analyzed for position (situs) of 3 organs: the heart,
stomach, and gallbladder [38]. Heterotaxia was defined
as reversal in position of one or more organs. Only
embryos with normal dorsoanterior development (DAI
= 5) were scored to avoid scoring instances of secondary
randomization due to errors in the dorso-ventral (DV)
or antero-posterior (AP) axial patterning [39], and only
clear left- or right-sided organs were scored. Percent
heterotaxia was calculated as the number with hetero-
taxia divided by the number of total scorable embryos, i.
e. embryos normal in all other ways. A c2 test was used
for further statistical analysis.
Whole amount in situ hybridization
Embryos were collected at different stages of development
and fixed in MEMFA for 3 hours at room temperature
and used for in situ hybridization as described in Harland
(1991). Plasmids containing Xenopus Mad3 and Xenopus
HDAC cDNA were purchased from Open Biosystems
(Mad3 clone ID: 4175511; HDAC clone ID: 6862376) and
cloned in pCS2. The plasmids were linearized and anti-
sense probes for in situ hybridization were generated in
vitro using DIG labeling mix from Invitrogen.
Xenopus embryo drug treatment
Batches of embryos were separated into experimental
and control groups and exposed to 0.1X MMR (control)
or 0.1X MMR containing 100 mM Sodium Butyrate
(NaB) (Sigma) during different stages of development.
The drug was washed out and the embryos were
allowed to develop until stage 21 for Nr1 in situ or until
stage 45 for organ placement score.
Western Blotting and Coimmunoprecipitation (CoIP) assay
For Western blottings embryos were collected at stage 7
(64 cells) and homogenized in lysis buffer (100mM
NaCl, 20 mMNaF, 50 mM Tris pH 7.5, 5 mM EDTA,
1%NP40, 1% deoxycholate, 1:50 EDTA-free Complete
protease inhibitor, Roche). The lysate was centrifuged
for 15 minutes at 4°C and the supernatant was collected
and frozen. The extracted proteins were subjected to
SDS-PAGE and blotted onto a PVDF membrane
(BioRad). After blocking with 5% skim milk and 0.1%
Tween 20 in PBS, membrane filters were incubated with
an anti-Mad3 (NeuroMab clone N129/15.1, supernatant)
or anti-acetyl H4 (Milipore 1:500) overnight at 4°C. The
membranes were washed in PBT and incubated with
secondary HRP conjugated antibody (1:1000, Jackson).
Immunosignals were visualized with chemoluminiscence.
For Co-IP assays, embryos were injected at the 1 cell
stage with Mad3WT-flag or Mad3-5mut-flag constructs
and collected at stage 7 (64 cells) when 10 embryos
were homogenized in lysis buffer. A total of 100 μl of
embryo lysate was incubated with 2 μg anti-5HT
(AB125, Milipore) or rabbit IgG for 3 hours at 4°C fol-
lowed by incubation with proteinA-agarose for 1 hour
at the same temperature. The beads were collected by
centrifugation and washed in lysis buffer. The samples
were then washed in low salt buffer (50 mM Tris HCl
pH 7.5, 0.1%NP40, 0.05% Deoxycholate) and high salt
solution (50 mM Tris HCl pH 7.5, 500 mM NaCl, 0.1%
NP40, 0.05% Deoxycholate). Proteins were eluted by
adding SDS-PAGE sample buffer followed by boiling for
5 minutes. For Western blotting embryo lysates were
loaded on 4-12% gradient polyacrylamide gel (Invitro-
gen) in sample buffer and the proteins were transferred
to a nitrocellulose membrane, blocked in 5% non- fat
milk in PBT (PBS plus 0.1% Tween 20) for 1 hour at
room temperature and incubated overnight with anti-
flag (Sigma; 1:1000). Membranes were washed with PBT
and incubated with secondary antibody conjugate to
HRP. The blotting was developed with a luminescence
kit (Pierce) and the images were acquired with a camera
coupled to a GBox system (Syngene).
To determine whether NaB treatment was effective,
whole embryo lysates were prepared from embryos
exposed to NaB at stages 1-7, stages 7-8, and stages 8-9,
including also untreated stage-matched controls. The
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whole lysate from treated and control groups were pre-
pared in the lysis buffer as described above and boiled
for 5 minutes. The proteins were separated by SDS-
PAGE and transferred to nitrocelulose membranes.
Blots were then incubated with anti-acetyl H4 (Milipore)
and developed with chemoluminiscence. To determine
the relative abundance of acetylated histone H4, mem-
branes were stripped of antibodies in 200 mM glycine
buffer pH 2.2 and re-probed with anti-Tubulina (Sigma,
1:4000). For quantification of acetylated histone H4 pro-
tein, the luminosity of individual bands was defined
using the histogram function of Photoshop and normal-
ized against Tubulin. Only exposures in the linear phase
of detection were used for quantification. SEM was
defined from normalized acetylated histone H4 and
measured in three independent experiments. Statistical
analysis was performed with Student’s t-test.
Chromatin preparation for Chromatin
Immunoprecipitation (ChIP) experiments
Embryos were exposed to 100 mM NaB from stage 1 to
7, when the drug was washed out and the embryos were
allowed to develop in 0.1X MMR until stage 21. The
chromatin was then collected and the ChIP was per-
formed following the protocol [40]. The purified chro-
matin from treated and control groups was then
incubated with anti-acetyl H4, anti-acetyl H3, anti-
H3K4me2 (Milipore) or anti-rabbit IgG (Milipore) as
control. Amplification of the precipitated DNA was car-
ried out in an Applied Biosystems Step One Plus PCR
machine, using the standard SYBR green program with
an initial melt stage at 95°C for 10 min, followed by 40
cycles of 95°C for 15 sec and 60°C for 1 min. The run
was finished by a melt curve from 95°C to 60°C to
ensure that no primer dimer artifacts were formed and
that cycle threshold (Ct) values represent the desired
amplicon. Primer sequences were designed with Primer
3 plus program (http://www.bioinformatics.nl/cgi-bin/
primer3plus/primer3plus.cgi).
qPCR primers set used: Nr1 intronic region: Forward
5’ - TTCCCTATTGACAGGGGTTG - 3’; Reverse 5’-
GCCAAATGTCAAAACACTCG -3’. Nr1 Promoter
region: Forward 5’ - TCCTTGATGAGGCCATTAGC -
3’: Reverse 5’ - CAAACAGAGCATTCCCTGAC - 3’.
The ΔΔCt method was used to represent the data as in
[41] and each experiment was performed in triplicate
and combined for further statistical analysis.
Chromatographic 5HT affinity capture screening
One gram of Sepharose 4BCL powder was activated
according manufacturer’s instructions, washed and equi-
librated in 4 mL buffer (50 mM TrisHCl, pH 7.5, 100
mM NaCl) plus 5 mM sodium metabisulfite to conju-
gate of 5-HT to the resin. Metabisulfite was added to
avoid rapid 5HT oxidation at the alkaline pH necessary
for the reaction. The 5HT capture was performed in
batch and metabisulfite 5 mM was added throughout
the whole process. Two 1 mL aliquots of conjugated
resin were centrifuged and then loaded with 1 mL of 1
cell embryo lysate prepared in lysis buffer (0.5% SDS;
150 mM NaCl; 5 mM EDTA; 10 mM Tris, pH. 7.6;
2mM PMSF at a final protein concentration of 15 mg/
mL) plus 20 mM 5HT (negative control) or 1 mL of 1
cell embryo lysate. The mixtures were incubated over-
night at 4 C, after which the resins were washed three
times at room temperature for one hour each with 50
mM TrisHCl pH 7.5, 100 mM NaCl at 4C to remove
loosely bound proteins. Elution was performed in both
cases by rotating the resin for one hour at room tem-
perature with the same buffer plus 20 mM 5HT. The
eluates were concentrated by centrifugational filtration
with a cutoff of 3 kDa. The proteins from each fraction
were subjected to a 10% SDS-PAGE and, after sample
preparation and trypsin in-solution digestion, the pep-
tide mixtures from the eluates were analyzed by LC/
MS-MS using a Dionex 3000 LC (Sunnyvale, CA)
coupled to a linear ion trap mass spectrometer (LTQ,
Thermo Fisher, San Jose CA). The raw data collected on
the LTQ was analyzed with Sequest software (Thermo
Fisher) for protein identification using a database for
Xenopus laevis.
Mad3 modeling and simulation methods
The protein sequence of Xenopus Mad3 transcription
factor (Q0VH33) was obtained from Swiss-Prot reposi-
tory (http://www.expasy.ch/sprot). To identify a suitable
template for modeling the 3D structure, the sequence
was queried against the protein databank (PDB)
sequences using Blast search engine [42]. Based on the
results from these analysis, the crystal structure of lipo-
calin AM182, which is a paralog of monotonin, in com-
plex with 5HT [43] was used as a template to model the
non-DNA binding region of Mad3, using the homology
modeling program MODELLER (ver 9.4, [44]. Ten mod-
els were built and ranked using the Modeller’s objective
function. The best ranking structure was subjected to
5000 energy minimization steps to relieve steric and
geometric strains using NAMD (Ver.2) with charmm
force field parameters. The 3D structure of 5HT was
obtained from the co-crystal structure of AM182, hydro-
gen atoms were added and the structure was minimized
using Amber charges and Amber force field as adopted
in MOE program (Ver.2008.10, http://www.chemcomp.
com). In the lipocalin structure, 5HT has salt bridge
with Asp106 and Ser18 [43]. Among class-A GPCRs (G
protein-coupled receptors), all biogenic amines including
5HT have a conserved salt bridge interaction with either
an aspartic acid or glutamic acid residue in the third
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transmembrane region that is required for agonist and
antagonist activity of GPCR ligands [45]. Based on this
evidence, the proposed site for docking 5HT in Mad3
structure was identified and consisted of Asp163,
Asp145, Asp148, Gln125, Gln161. 5HT was docked to
the proposed binding site using the docking software
Gold (v4.1) [46]. Twenty independent runs were per-
formed to completely sample the ligand conformation
and to avoid local minima and all the docked complexes
were scored using Goldscore [46] and chemscore [47].
The best ranking complex was minimized using MOE
as described above.
Mad3 and 5HT in vitro interaction assay
Recombinant proteins
For use in binding experiments, Mad3 protein was
obtained as a fusion protein with glutathione-S-transfer-
ase (GST) by transgenic expression in Escherichia coli
and subsequent purification using glutathione (GSH)-
agarose affinity chromatography. Briefly, the full Mad3
coding sequence was amplified by PCR using previously
cloned Mad3 cDNA from human cell lines as a tem-
plate. PCR reactions were performed under standard
conditions using Pfx DNA polymerase (Invitrogen). PCR
products were cloned into pCR-Blunt II-TOPO (Invitro-
gen) and subsequently subcloned into pGEX-5X-1 (GE
Healthcare) using BamHI/SalI sites introduced by the
PCR primers. All constructs were confirmed by sequen-
cing. To express GST-Mad3, transformed E. coli BL21
were grown overnight at 37°C, diluted 200-fold in fresh
medium and grown at room temperature until OD600 =
0.5-0.8. The culture was induced with 0.1 mM IPTG for
3 hours at room temperature. To express GST, E. coli
BL21 were transformed with the empty vector, grown at
37°C to OD600 = 0.5-0.8 and induced with 1 mM IPTG
for 1 hour at 37°C. After induction, pelleted cells (6,000
× g, 20 minutes, 4°C) were resuspended in 5 ml BugBus-
ter protein extraction reagent (EMD Biosciences) per
gram of wet cell paste and lysed with 100 μg/ml each
lysozyme and DNAse I for 20 minutes at room tempera-
ture. Lysates were cleared by centrifugation for 20 min-
utes at 16,000 g and the supernatants were applied
directly to a GSH-agarose column. Proteins were puri-
fied using standard procedures. Bound proteins were
eluted with 25 mM GSH/50 mM Tris pH 8. The eluates
were concentrated and the buffer changed to HBS-EP
(10 mM Hepes pH 7.4, 150 mM NaCl, 3 mM EDTA,
0.005% surfactant P20) using an Amicon Ultra-15
device. Typically, GST was expressed in large quantities
in the soluble fraction, while GST-Mad3 was found
mostly in inclusion bodies, with a small percentage in
the soluble fraction from which it was purified. Protein
concentration was determined by the BCA method and
the purity of the fractions was confirmed by SDS-PAGE.
Surface Plasmon Resonance
Binding experiments were carried out on a Biacore X
system (GE Healthcare). Proteins of interest were immo-
bilized on a CM5 chip using the Amine Coupling Kit
(Biacore, GE Healthcare). Specifically, two cells on a
CM5 chip were activated using a 1:1 ratio of N-hydroxy-
succinimide (NHS):1-ethyl-3-(3-dimethylaminopropyl)
carbodiimide (EDC) at a flow rate of 5 μl/min for 10
min. Recombinant GST and GST-Mad3 proteins were
prepared as described above at a final concentration of
50 μg/ml and 10 μg/ml respectively in HBS-EP buffer
(GE Healthcare). Prior to injection, 40 μL of protein
solution were mixed with 30 μL of 100 mM Glycine pH
2.5, since these were the optimum conditions for cap-
ture as determined by pre-concentration experiments.
GST was immobilized in the reference cell Fc2 by one
10 μL-injection at 10 μL/min. GST-Mad3 was immobi-
lized in the sample cell Fc1 by five 20 μL-injections at
10 μL/min. Both Fc1 and Fc2 were subsequently blocked
with 1 M ethanolamine (pH 8.5) for 7 min at 10 μl/min.
A total of 7,962 response units of GST and 6,938
response units of GST-Mad3 were immobilized. Binding
of 5HT was carried out at 25°C at 160 μL/min in HBS-
EP. The amount of specific analyte bound was moni-
tored by subtracting the response units from the refer-
ence cell (GST) from the GST-Mad3 immobilized cell.
After each analyte injection, surfaces were regenerated
with 50 mM NaOH for 0.25 sec at 160 μL/min. All sen-
sorgram data presented are representative of at least 3
runs. Sensorgrams were aligned to the injection time
(defined as t = 0 s) using BiaEvaluation software, and
the baselines averaged at response difference = 0 RU.
Curve fitting and binding kinetics parameters were cal-
culated using GraphPad Prism Software.
Results
The epigenetic machinery controlled by HDAC is involved
in LR patterning upstream of Nodal related 1 expression
Xenopus embryos express a maternal form of HDAC
mRNA that shows sequence homology to other HDACs
[29]. The HDAC activity present in early embryos
appears to be mainly, if not exclusively, of the HDAC-A
type, that is of the vertebrate HDAC I class [30].
Although the biochemical properties of the Xenopus
HDAC are well characterized [30], knowledge about its
mRNA expression pattern is limited. We processed dif-
ferent stages of early embryos for in situ hybridization.
HDAC mRNA was found to be expressed in all animal-
pole blastomeres by the 64 cell stage (stage 7) (Figure
1A).
To probe the overall potential involvement of HDACs
during Xenopus LR patterning, we injected early
embryos with mRNA encoding a well-characterized
dominant negative (DN) form of the Xenopus HDAC
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Figure 1 Early HDAC mRNA injection induces heterotaxia. (A) Xenopus HDAC mRNA expression pattern is shown by in situ hybridization with
early Xenopus embryos. HDAC mRNA presents a symmetric expression pattern by animal cells at the stage 3 (4 cells) (a,b,c), at the stage 5 (16
cells) (d,e,f) and at the stage 7 (64 cells) (g,h,i). in situ reaction control with no secondary (j, animal view) or no probe added to the reaction (k,
animal view; l, vegetal view). (B) Embryos injected with HDAC DN on the ventral or dorsal right blastomeres presented significant levels of
heterotaxia (VR 20% heterotaxia p < 0.01, n = 55; DR 19% heteroatxia p < 0.01, n = 42; VL 7% heterotaxia p = 0.3 n = 55; DL 2% heterotaxia p =
0.7). Embryos injected with HDAC WT on the ventral left side presented significant levels of heteroatxia (VL 19% heterotaxia p < 0.01, n = 68; VR
4% heterotaxia p = 0.8, n = 49; DL 4% heteroataxia p = 0.8, n = 44; DR 2% heterotaxia p = 0.5, n = 50). (B`) Schematic showing the injected
blastomere at the 4 cell stage. (I) Wild type phenotype showing the gut coil to left (yellow arrow), the gall bladder on the right (green arrow)
and the heart loop on right (red line). (II) Situs inversus phenotype where all three organs analyzed are found inverted. (III) Heterotaxic phenotype
showing the heart loop to the left (red arrow).
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[36]. Embryos in which the DN HDAC mRNA was
injected at the 1 cell stage exhibited a 17-fold increase
in heterotaxia compared to controls (17% vs. 1% hetero-
taxia in control non injected embryos, n = 62, significant
at p = 0.002), demonstrating that HDAC is indeed func-
tionally involved in embryonic LR patterning in Xeno-
pus. It should be noted that the penetrance of the
phenotype is artificially reduced (compared to those
reported in mouse models, which often have midline or
other defects) in these experiments by titering down the
reagents to sub-optimal levels (because of our stringent
requirement of normal dorso-anterior index and purity
of LR phenotype). Nevertheless, given the very low
background incidence of heterotaxia in un-manipulated
embryos, the level of laterality disturbance induced by
our manipulations is unmistakably significant. Moreover,
when scoring three organs for situs, the maximum level
of heterotaxia is 87.5%, not 100%, since random inde-
pendent assortment of 3 organs will sometimes result in
a wild-type phenotype being mistakenly scored when all
three organs randomly land in their correct positions.
Next we sought to investigate whether the left and
right sides of the embryo require different levels of
HDAC activity for proper organ situs. To test this
hypothesis, we injected embryos at the 4 cell stage on
the left (ventral or dorsal) or on the right (ventral or
dorsal) side with the constructs HDAC DN or HDAC
WT. Indeed, embryos injected in either right blasomere
with the HDAC DN, and embryos injected with HDAC
WT on the left side, exhibited heterotaxia at stage 45
(Figure 1B). Embryos injected on the dorsal left side
with HDAC DN or HDAC WT did not present signifi-
cant levels of heterotaxia when compared to un-injected
controls.
These data are consistent with a role for histone acet-
ylation during LR development and demonstrate a LR-
differential dependence on endogenous HDAC activity.
Importantly, these data are not consistent with involve-
ment of the HDAC pathway in cilia-driven events in the
gastrocoel roof plate (GRP). The ciliated GRP cells
derive from the dorsal precursors [48], whereas our
results show effects on ventral blastomere descendants
(which do not contribute to the ciliated organ); more-
over, it is now known that only the left side of the
nodal flow is important for asymmetry at neurula stages
[49], while our data reveal effects on the descendants of
right-side blastomeres.
As Nr1 is the most upstream gene known in the
asymmetric cascade of the frog embryo (expressed only
on the left side), we processed injected embryos at the
stage 21 with a probe for Xenopus Nr1 1 (Xnr-1) in
order to determine whether the pattern of Xnr-1 expres-
sion was disrupted when early HDAC activity was per-
turbed. Indeed, embryos injected on the right side with
HDAC DN or on the left side with HDAC WT exhib-
ited a loss of the normal asymmetry of Xnr-1 expression
(HDAC DN on the right: 50% absence of Xnr-1; HDAC
WT on the left: 26% bilateral expression of Xnr-1 with
only 5% of control embryos not showing Xnr-1
expression).
These results support a role for HDAC activity in LR
establishment and suggest that the epigenetic status of
the chromatin may play a key role in determining the
normally left-sided expression of Xnr-1.
Only early Xenopus HDAC blockade affects the Left Right
Establishment
We next characterized the timing of epigenetic controls
of Xnr-1 expression, probing the function of HDAC at
the early developmental stages when 5HT signaling
takes place [15]. We used a HDAC blocker, Sodium
Butyrate (NaB), capitalizing on the ability to use phar-
macological reagents at different developmental stages
(mRNA injections do not offer temporal control). Xeno-
pus HDAC class I activity present in early embryos has
already been shown to be sensitive to HDAC blockers
[30].
Embryos at different developmental stages were sepa-
rated into control groups and experimental groups and
the latter were exposed to 100 mM NaB (Figure 2A).
Incubation of embryos with NaB induced heterotaxia
when exposures occurred between stage 1 and 7 (Figure
2B). Exposure to NaB at any stage after stage 7 did not
induce heterotaxia (Figure 2B and Table 1), confirming
that the LR-relevant functions of HDAC took place at
cleavage stages (under zygotic transcriptional silence
and long prior to cilia-mediated flow).
We also processed NaB treated embryos for Xnr-1 in
situ hybridization in order to correlate levels of hetero-
taxia with misexpression of Xnr-1. Interestingly, a high
percentage of embryos exposed to NaB lacked Xnr-1
(64% of Xnr-1 absence; Control: 5%). This reproduced
the loss of Xnr-1 expression resulting from the HDAC
DN mRNA microinjection (that was absence of Xnr-1
expression).
Thus, these results indicate that the time window
most sensitive to blockage of HDAC overlaps with the
developmental window in which the 5HT pathway was
shown to be active [15].
HDAC blockade increases the levels of acetylated histone
H4 in the early embryo
Given that the normal function of HDAC is associated
with a loss of immunoreactivity related to acetylated
nuclear H4 [36], and as histone H4 is found in the
Xenopus egg and early embryos [50,51], we investigated
the impact of NaB-induced HDAC blockade on global
H4 acetylation levels. Whole protein lysates from
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Figure 2 HDACs exert stage specific effect on left-right patterning. (A) Schematic showing the experimental procedure for NaB treatments.
Embryos were exposed to 100 mM NaB from stage 1 to 7 (solid black line) and the drug was washed out (dashed black line). Embryos were
collected at stage 7 for anti-acetyl H4 western blotting or were allowed to develop in 0.1X MMR until stage 45 to score organ placement or
until stage 21 for ChIP experiments. (B) 100 mM NaB treatment exerts stage specific effects on left-right development. Embryos that were
exposed to NaB between stage 1-7 presented significant levels of heterotaxia (100 mM NaB: 22.5%, p < 0.001). NaB exposure after stage 7 does
not affect left-right development (stage 7-8 and stage 8-9). (C) NaB treatment led to a significant increase in the H4 acetylation levels. Embryos
exposed to NaB from stage 1 to 7 presented 1.8 fold increase, stage 7-8 presented 2.3 fold increase and stage 8-9 presented 2.3 fold increase on
the levels of acetylated histone H4 when compared to controls. (* p < 0.05).
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embryos exposed to NaB were analyzed by western blot-
ting with a specific antibody against acetylated histone
H4. This analysis showed that the histone H4 acetyla-
tion levels were markedly increased by 100 mM NaB
treatment compared with control groups (Figure 2C).
There was a 1.8-fold increase in acetylation levels in
embryos exposed from stage 1-7, and a 2.3-fold increase
in embryos exposed from stage 7 to stage 8 or from
stage 8 to stage 9 (Figure 2C).
These results are consistent with HDAC functioning
in the control of histones’ acetylation levels during its
regulation of LR asymmetry establishment.
The Xnr-1 intronic region that contains the asymmetric
element is targeted by the epigenetic machinery
Our data indicate that very early epigenetic modifica-
tions control expression of Xnr-1 at a much later devel-
opmental stage. Thus, we tested the prediction that this
epigenetic modification was made directly on the Xnr-1
gene. The Xnr-1 genomic region is composed of 2 main
regulatory elements (RE). The RE on the promoter
region (PRE) is located 230 bp from the start codon
[52]. The second RE is the ASE (asymmetric element) in
the intron 1 of the Xnr-1 gene. It is known to drive the
asymmetric expression of Xnr-1 in the Lateral Plate
Mesoderm (LPM) [53] (Figure 3A).
Because early HDAC activity is necessary for the
expression of Xnr-1 at stage 21, we asked whether the
deposition of epigenetic markers due to early HDAC
blockade could cause Xnr-1’s repression later in devel-
opment. More specifically, we also sought to map which
region of the Xnr-1 gene (the promoter or the intronic
region that contains the asymmetric element) was a tar-
get for the HDAC machinery, and link the deposition of
epigenetic markers to the repressed state of Xnr-1
induced by NaB treatment. We performed a Chromatin
Immunoprecipitation (ChIP) assay with chromatin from
embryos at stage 21 that had been exposed to NaB early
during development. We focused on three different mar-
kers: acetylated histones H4 and H3 (as HDAC inhibi-
tion leads to increased levels of histone acetylation), and
H3K4me2, because of the existence of crosstalk between
histones’ modifications [54] and the fact that H3K4me2
modification is also associated with a repressed state of
chromatin [55,56]. The H3H4me2 marker was particu-
larly interesting because it has been associated with the
epigenetic memory that precedes transcriptional control
by several hours [57], thus being an attractive candidate
to transmit an epigenetic memory from early to late
developmental stages in absence of transcription.
Embryos were exposed to 100 mM NaB from stage 1
to 7 and allowed to develop in plain MMR medium
until stage 21. At this stage the chromatin was isolated
as described [40,41]. The ChIP experiment followed by
qPCR analysis revealed that the level of acetylation of
histones H3 and H4 and the levels of H3K4me2 in
embryos exposed to NaB early during development pre-
sented increased levels only on the intronic region (Fig-
ure 3B), suggesting that higher levels of acetylated H3
due to HDAC treatment led to deposition of di-methy-
lated H3 on the intronic region.
Taken together, these results indicate that NaB treat-
ment during early cleavage stages led to a hyperacetylated
status of the chromatin and perturbed LR-relevant gene
transcription occurring at late developmental stages.
A high-throughput proteomic analysis identified the
HDAC partner Mad3 as a new component in 5HT
signaling pathway
Our evidence for epigenetic mechanisms operating at
cleavage stages controlling much later transcriptional
readouts in LR patterning led us to investigate how
HDAC activity could be modulated during early devel-
opment. Our model predicts such controls, because the
HDAC mRNA is expressed symmetrically; thus, an
asymmetric signal is needed to confer the observed con-
sistent difference in HDAC activity on the L and R
sides. Because rightward redistribution of maternal sero-
tonin (5HT) during cleavage stages has been shown to
be necessary for the establishment of LR asymmetry
[14,16], we sought mechanisms by which 5HT could
couple to the epigenetic machinery.
We performed a high-throughput proteomic assay to
identify novel 5HT binding proteins (SBP) present in the
Table 1 NaB treatment affects Xenopus left-right development
100 mM NaB stage 1-7 stage 7-8 stage 8-9 stage 13-19 stage 13-15 stage 15-19 stage 19-22
Percent Heterotaxic 22.5% 2% 1.2% 0 0 0 0
Non-scorable 0 0 0 100% 100% 100% 100%
n 145 168 176 150 120 145 160
p value P <0.001 p = 0.6 p = 0.8
NaB treatment affects Xenopus left-right patterning.
Embryos were exposed to 100 mM NaB during different stages of development, the drug was washed out and the embryos were allowed to develop until at
stage 45 for organ placement score. NaB treatment induced significant levels of heterotaxia if embryos were exposed to the drug from stage 1 to 7. Embryos
exposed to the drug during Xenopus ciliogenesis (stage 13-19; 13-15; 15-19) or during Nr-1 asymmetric expression in the lateral mesoderm plate (stage 19-22)
presented significant malformations and thus could not be used for laterality assessment.
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cytoplasmic fraction that may interact with known epige-
netic machinery. A resin conjugated with 5HT was used
for affinity capture analysis from whole protein lysate of
Xenopus laevis embryos at the 1 cell stage. Two aliquots
of 5HT-conjugated resin were loaded with either frog
embryo lysate plus 20 mM 5HT (negative control) or
frog embryo lysate (test). The eluate from both experi-
ments was subjected to a 10% SDS-PAGE and, after
proper sample preparation and trypsin in-solution diges-
tion, the peptide mixtures were analyzed by LC/MS-MS.
Figure 3 HDAC inhibition leads to increased levels of acetylated histones and H3K4me2 on the XNr-1 gene. (A) Schematic showing the
structure of the Xenopus Nr-1 gene. Light gray boxes represent the protein-coding and the dark gray box represents the promoter region
(adapted from [53]). Intronic regions 1 and 2 are indicated. Red and blue arrows represent the primer set used for qPCR reaction for the
promoter and intronic region, respectively. (A1) The red lines indicate the sequence of the XNr-1 promoter region used to design the primer set
for qPCR reaction. (A2) The regions underlined show the sequence used for primer set design. In purple are highlighted the FAST binding
domains as in [53] and the black CATTTG indicates two putative Mad binding sites. (B) Chromatin isolated from embryos exposed to NaB from
stage 1-7 and allowed to develop until stage 21 in 0.1X MMR was used for ChIP with anti-acetyl H4, anti-acetyl H3, anti-H3K4me2 and rabbit IgG
(Control) followed by qPCR analysis against the promoter region (gray bar) and intronic region (black bar) of XNr-1. The levels of acetylated H4
and H3 and H3K4me2 were increased only on the intronic region (black bars).
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The raw data collected from the ion trap mass spec-
trometer was analyzed for protein identification using a
database for Xenopus laevis. The screen identified 11
proteins as possible 5HT interactors. Because we were
interested in mechanisms by which intracellular 5HT
binding proteins could couple to the cytoplasmic epige-
netic machinery (as 5HT is delivered inside the cell, via
gap junctions [16]), we focused on candidate proteins
with known interactions with HDAC proteins and/or
DNA-binding domains. We did not recover the classical
5HT transmembrane receptors in this screen, since we
focused our analysis on the cytoplasmic (not the plasma
membrane) protein fraction. Indeed, our screen success-
fully identified 10 candidates with characteristics of
cytoplasmic proteins and 1 candidate having a DNA
binding domain. This DNA binding-protein was identi-
fied as the Max-interacting transcriptional repressor
Mad3. Mad3 is involved in the control of the epigenetic
state of cells, since it can antagonize transcription by
recruiting co-repressor complexes that contain HDAC I
[58]. Indeed, the repressive activity of Mad proteins has
been shown to be due to HDAC activity and inhibited
by HDAC blockers [59]. Mad proteins also interact with
Max, and this complex has been implicated in different
aspects of cell biology and cancer transformation [60].
Mad3 protein and mRNA are present in the early embryo
A role for Mad3 as a new player in the 5HT signaling
pathway during LR patterning requires that Mad3 protein
be already present in early embryos. Indeed, Mad3 mRNA
is present in the blastomeres at the 4-cell stage by in situ
hybridization (Figure 4A). By the 32-64 cell stage (stage 6-
7), Mad3 mRNA is found only in the animal cells.
To validate the presence of Mad3 protein in early
embryos, as detected on the ion trap mass spectrometer,
we performed two different sets of analysis. In the first
strategy we used a monoclonal anti-Mad3 antibody to
detect the endogenous Mad3 protein in embryos at
stage 7 (Figure 4B, lane 1). To confirm the specificity of
this anti-Mad3 antibody we injected embryos with the
Xenopus Mad3 protein fused to the flag epitope at the 1
cell stage. The lysate was collected at the stage 7 and
used for immunoblotting to detect the exogenous Xeno-
pus Mad3. Indeed, the injected Mad3-flag protein was
detected migrating at 30 kDa, the expected molecular
size for the Xenopus Mad3 protein (Figure 4, lane 4).
Taken together these results confirm that Mad3 is pre-
sent as a maternal mRNA and protein at the early clea-
vage stages and thus is potentially available for
interaction with 5HT and/or HDAC.
Mad3 is a new player during Xenopus LR patterning
To examine a role for Mad3 during LR patterning, we
utilized 2 different constructs encoding loss-of-function
and gain-of-function reagents for Mad3: Mad3Vp16 (a
constitutively active form of Mad3) and EngMad3 (a
constitutively repressive form of Mad3) [61].
To probe the requirement of Mad3 between the left
and right side of the embryo, the single dorsal or ven-
tral, left or right blastomeres at the stage 3 (4 cells)
were injected with mRNA encoding EngMad3 or
Vp16Mad3 along with the lineage tracer lacZ mRNA.
The embryos were then scored for organ placement at
stage 45. Whereas dorsal injections led to considerable
toxicity, ventral left or right expression of the EngMad3
(repressive) construct induced heterotaxia at a statisti-
cally significant level when compared to control Eng-
expressing embryos (Figure 5A). Conversely, embryos
injected with Vp16Mad3 in the right ventral blastomere
presented significant heterotaxia when compared with
Vp16 control injected embryos (Figure 5A).
We also analyzed injected embryos with EngMad3 or
Vp16Mad3 by in situ hybridization with a Xnr-1 probe.
Indeed, embryos expressing the repressive EngMad3
construct on the left or right side showed Xnr-1
absence, and embryos injected with the activating
Vp16Mad3 on the right showed a consistent level of
bilateral Xnr-1 expression (Figure 5B).
Thus, Mad3 gain-of-function on left (EngMad3) and a
Mad3 loss-of-function on the right (Vp16Mad3) can
both control Xnr-1’s transcriptional status. Taken
together, these results support Mad3 as a new LR deter-
minant, and are consistent with a role for Mad3 as a
modulator of Xnr-1 expression.
The Mad3 biological activity during LR establishment is
dependent on 5HT
Next we tested whether Mad3’s biological activity is
dependent on 5HT. The first strategy was to carry out a
binding assay using surface plasmon resonance (SPR)
[62]. Recombinant Mad3 protein expressed as a fusion
with glutathione S-transferase (Mad3-GST) was immobi-
lized in a Biacore chip and a 5HT solution was then
passed over the surface. To subtract possible non-speci-
fic binding, we used a reference surface in the same
chip where GST alone was immobilized. 5HT showed a
high association rate and a low dissociation rate (Figure
6A). Four different concentrations were examined, ran-
ging from 400 μM to 2 mM. Using a 1:1 Langmuir fit-
ting algorithm, we calculated the equilibrium
dissociation constant to be in the range of 6.7 to 26 μM
(95% confidence). Based on the 5HT levels found in
early embryos, 3.11 pmol/egg [15], we measured embryo
diameters in order to calculated the endogenous con-
centration of 5HT. Considering the whole embryo as a
sphere (diameter = 1mm), 5HT concentration can then
be calculated as 5.7 μM, which is very close to the Kd
values determined in vitro. It should be noted that 5HT
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is not homogeneously distributed in the whole embryo
but concentrated in the right blastomeres descendants
at the stage 7 [15]; therefore, the local concentrations
could be even higher than the ones calculated here, well
above the determined dissociation constant. Hence,
these in vitro data does suggest that 5HT and Mad3
form a complex in vivo.
The second strategy was to generate a Mad3 mutant
lacking 5HT-binding sites. To generate this Mad3
mutant first we mapped the putative 5HT binding sites
on Mad3 by modeling the 3-dimensional structure for
Mad3 using the crystal structure of a lipocalin AM182,
a well characterized 5HT-binding protein, complexed
with 5HT [43]. We chose lipocalin because among all
known 5HT binding proteins, including class-A GPCRs
(G protein-coupled receptors), a conserved salt bridge
interaction exists between the amine group and an
aspartic acid or glutamic acid residue on the protein
[45,63-65]. In lipocalin AM182, this conserved salt
bridge is formed between Asp106 and the amine group
of 5HT. The structural equivalent aspartic acid in Mad3
is Asp163. Thus the potential binding site for 5HT in
Mad3 was derived based on the corresponding binding
site residues from lipocalin structure.
To gain insight into the physiological relevance of
these putative 5HT binding sites on Mad3, we per-
formed functional experiments with a Mad3 mutant
generated based on the structural modeling. Based on
the docking mode of 5HT in the Mad3 structure, resi-
dues D145, D148, D163, Q125 and Q161 are proposed
to form important components of the 5HT binding
pocket on Mad3 (see Material and Methods). An evalua-
tion of the binding site residues was performed by
designing a Mad3-5mut-flag construct harboring muta-
tions on the five amino acids predicted to be involved in
the 5HT putative binding site (Q125E, Q161E, D145N,
D148N and D163N). Embryos injected with Mad3-WT-
flag at the 1 cell stage developed significant levels of
randomization of the heart, gut and gall bladder (hetero-
taxia) in the absence of other defects and with normal
dorsoanterior development at stage 45; in contrast, the
Mad3-5mut did not induce this phenotype (Figure 6C,
Mad3 WT 17%, p < 0.001, n = 93; Mad3-5 mut 2%, p =
0.7, n = 90).
To confirm that the lack of biological activity pre-
sented by the Mad3-5mut-flag was due to the abroga-
tion of the 5HT putative binding site, we performed a
Co-IP assay with a 5HT antibody. Because 5HT is
evenly distributed in embryos from stage 1 (1 cell)
through stage 5 (16 cells), we injected embryos at the 1
cell stage to probe Mad’s ability to bind to any available
5HT present in the embryo, and in turn, to test if this
ability would be lost in Mad3-5mut injected embryos.
Embryos were then injected at the 1-cell stage with
Figure 4 Xenopus Mad3 mRNA and protein are present in early
embryos. (A) Mad3 mRNA is expressed by animal cells in a
symmetric pattern at the stage 3 (4 cells) (I,II,III), at the stage 5 (16
cells) (IV,V,VI) and at the stage 7 (64 cells) (VII,VIII,IX). Figure X: in situ
reaction control, animal view (no secondary antibody added to the
reaction); XI and XII: no probe added to the reaction, animal and
vegetal view, respectively. (B) Immunoblotting using stage 7 (64
cells) whole embryo lysate with an anti-Mad3 antibody. Lane 1:
Whole lysate from stage 7 embryos. Anti-Mad3 recognizes a band
running at 30 kDa. Lane 2: Immunoblotting control with no primary
antibody added to the membrane. Lanes 3 and 4: Whole protein
lysate from non injected (lane 3) or Mad3WT-flag injected embryos
(lane 4) were used to detect exogenous Mad3.
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Figure 5 Mad3 is a new left-right determinant. (A) Single ventral left or ventral right blastomeres were injected with EngMad3 or Vp16Mad3
constructs and organ placement was scored at stage 45. Significant levels of heterotaxia were observed when embryos were injected with
EngMad3 (left: 21%, n = 96, p < 0.001; right: 12%, n = 91, p = 0.005; control: Eng) or with Vp16Mad3 on the right side (17% n = 90, p < 0.001;
6% n = 127, p = 0.1, control: Vp16). (B) Embryos injected with EngMad3 or Vp16Mad3 were processed for in situ hybridization at stage 21 with a
XNr-1 probe. XNr-1 misexpression was correlated with Vp16Mad3 injection (right injected embryos: 19% bilateral expression, n = 117; left injected:
5% bilateral expression, n = 105) and EngMad3 (left injected: 75% no expression, n = 74; right injected: 21% no expression, n = 93) if compared
to control embryos (uninjected, 10% no expression, n = 103). (B’) XNr-1 expression pattern characterized in EngMad3 or Vp16Mad3 injected
embryos. I- Left expression indicated by the white arrow; II-right expression indicated by the gray arrow; III- Bilateral XNr-1 expression indicated
by the two blue arrows; IV- Absence of XNr-1 expression as indicated by the two black arrows.
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Figure 6 Mad3’s biological activity depends on 5HT. (A) Sensorgram of serotonin binding to GST-Mad3. Data represent the difference
between the sample cell (GST-Mad3) and the reference cell (GST). A blank run (buffer only) has been subtracted from all curves. Four different
analyte (5HT) concentrations (2, 1.5, 1, 0.8 and 0.4 mM were injected). Injection start and stop are indicated by arrows. The data shown are
representative of 3 independent experiments. (B) Embryos were injected at stage 1 with Mad3 WT or Mad3-5mut and scored for left-right
phenotype at stage 45. Embryos injected with Mad3 WT presented significant levels of heterotaxia (17%, n = 52, p = 0.001) whereas Mad3-5mut
injected embryos presented only 2% of heterotaxia (n = 104, p = 0.7) when compared to control group. (C) Co-Immunoprecipitation assay.
Xenopus embryos at the 1 cell stage were injected with Mad3 WT-flag (lanes 1,2,3) or Mad3-5mut-flag (lanes 4,5,6) and collected at the stage 7
(64 cells). The whole protein lysates were incubated with anti-5HT antibody followed by protein-A agarose. Lane 1: 10% Input; Lane 2: whole
lysate from Mad3 WT-flag injected embryos plus anti-5HT; Lane 3: negative control (whole lysate from Mad3 WT injected embryos plus rabbit
IgG); Lane 4: 10% input; Lane 5: whole lysate from Mad3-5mut-flag injected embryos plus anti-5HTLane 6: negative control (whole lysate from
Mad3-5mut-flag plus rabbit IgG).
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Mad3WT-flag or Mad3-5mut-flag and whole embryo
lysate was prepared at the stage 7 (64 cells) and incu-
bated with ati-5HT followed by immunoblotting with
anti-flag. As predicted, the Mad3-5mut-flag protein was
not found in complex with 5HT (Figure 6C, lanes 4,5,6)
when compared to the Co-IP performed with Mad3
WT-flag injected embryos (Figure 6, lanes 1,2,3). These
results confirm the importance of these 5 residues for
the Mad3 biological activity during laterality establish-
ment due to 5HT. We conclude that serotonin binding
is a key component of Mad3’s ability to functionally par-
ticipate in LR patterning.
Discussion
Chromatin structure and epigenetic state as a new source
of asymmetric information
The importance of chromatin remodeling for cancer and
developmental biology is increasingly appreciated [66].
The epigenetic state of the cell can be characterized by
modifications on histone proteins such as acetylation,
methylation, phosphorylation and ubiquitination [67].
One important epigenetic state is characterized by the
levels of histone tail acetylation that are tightly con-
trolled by HDACs [68].
Previous work has shown that the Xenopus HDAC
protein is found at high concentrations in the oocyte
nucleus and its levels remain constant through oocyte
maturation, fertilization, and early cleavage stages but
decreases after the blastula stage [29]. Measurements of
Xenopus HDAC activity indicate that it also remains
constant from oogenesis until early embryogenesis and
that it is sensitive to HDAC blockers [30], which is con-
sistent with the data we obtained on its role in the early
LR pathway. In addition, our study indicates that
although HDAC mRNA is expressed in all animal blas-
tomeres, HDAC activity on the right side is important
for LR, as HDAC DN injections on the right side led to
heterotaxia that was correlated with absence of Xnr-1
expression. In addition, NaB treatment shows that the
critical HDAC activity for LR development overlaps
with 5HT signaling (right blastomeres) during cleavage
stages and takes place before cilia flow (Figure 2). The
results of the molecular-genetic loss-of-function (domi-
nant negative construct misexpression) confirm the tar-
geting of the pharmacological reagent (NaB), while the
latter offers the opportunity of temporally-limited
exposure.
Our results using the ChIP and qPCR analyses indi-
cated that HDAC inhibition led to accumulation of his-
tones H3 and H4 and the epigenetic marker H3K4m2 in
the intronic region of Xnr-1. This region is particularly
critical for Xnr-1 asymmetric expression and we propose
that HDAC activity targets this region of the Xnr-1
gene. Although the H3K4me2 marker has been
associated with transcriptional activation when it occu-
pies promoter regions [69], it was also shown to be
associated with repression [55]. Interestingly, H3K4me2-
enriched regions do not correlate with transcription
start sites and have been proposed to control chromatin
states over regulatory regions [70]. This feature is parti-
cularly interesting as H3K4me2 was found enriched only
on the intronic region of Xnr-1 that contains the asym-
metric regulatory element. One hypothesis is that, after
drug removal, the H3K4me2 marker remained stably
tethered on the Xnr-1 intronic region and led to its
repression due to the recruitment of zygotic HDACs
during late developmental stages.
The function of Mad3 in the LR establishment
In agreement with our result indicating that the HDAC
block leads to an increase in histone H4 and H3 acetyla-
tion levels, Mad signaling was shown to be important in
the control of global levels of chromatin structure also
characterized by acetylation of heterochromatin regions.
Indeed, Mad proteins have been shown to coordinate
chromatin modifications resulting in a significant
decrease in acetylated histones H3 and H4 in cell cul-
ture [71].
A key feature of 5HT signaling during Xenopus LR
development is that it functions during cleavage stages,
prior to mid-blastula transition (MBT), and thus largely
under zygotic transcriptional silence. It was previously
shown that early 5HT signaling is important to the cor-
rect placement of Xnr-1 expression on the left side of
embryo [15]. Indeed, constitutive repressive form of
Mad3 protein (EngMad3) can induce heterotaxia and
blocks Xnr-1 expression on the left side (Figure 5),
which indicates its endogenous role as a repressor of
Xnr-1. On the other hand, Vp16Mad3 injections could
relieve the repressive state of Xnr-1 on the right side
leading to its ectopic expression at stage 21 (Figure 5).
In contrast to transcriptional control of Xnr-1, we pro-
pose that the EngMad3 phenotype is due to a constitu-
tive recruitment of repressive elements of the cell
machinery that can lead to a repressive state of the
chromatin that can be maintained throughout develop-
ment. Conversely, the Vp16Mad3 phenotype is compati-
ble with an open chromatin structure leading to the
ectopic induction of Xnr-1. Interestingly, injections with
the HDAC DN and Vp16Mad3 on the right and HDAC
WT and EngMad3 on the left gave rise to consistent
heterotaxia, indicating that Mad3 and HDAC functions
during LR establishment take place in the same subset
of blastomeres and may converge on Nr1. This hypoth-
esis is corroborated by the presence of 2 putative Mad
binding sites CANNTG [72] in the intronic region of
Nr1 (Figure 3A2). Interestingly, the second site is placed
in the region that contains the FAST binding sites that
Carneiro et al. BMC Developmental Biology 2011, 11:29
http://www.biomedcentral.com/1471-213X/11/29
Page 15 of 19
are important to proper control the asymmetric expres-
sion of Nr1 in the left side of the embryo [53]. This
interesting feature suggests that Mad protein could bind
to this region of the Nr1 gene. This analysis, along with
the established status of Mad3 as a very well-character-
ized partner for HDACs, indicates that 5HT/Mad3 sig-
naling could couple to repressive elements belonging to
the epigenetic machinery of the early embryo. In addi-
tion, HDAC and Mad3 mRNA symmetric expression
patterns argue in favor of a symmetric distribution for
both proteins. In this context, we hypothesize that 5HT
binding on Mad3 would be an asymmetric signal impor-
tant to confer specificity for HDAC activity in the con-
text of LR development, decreasing the levels of histone
acetylation on the Nr1’s intronic region (Figure 7).
Indeed, a recent study has demonstrated an antide-
pressant-like effect for HDACs inhibitors similar to the
effects of fluoxetine, an effective inhibitor for 5HT re-
uptake, [73] that randomizes LR asymmetry [16]. These
data suggest a synergistic role for 5HT and HDAC path-
ways, indicating they may be acting in the same pathway
and reinforcing our model that brings together 5HT and
epigenetic machinery.
How is the early LR signaling pathway transduced into a
stable gene expression pattern at a late developmental
stage?
In Xenopus and many invertebrates, consistent asymme-
try is determined by very early biophysical and physiolo-
gical events taking place long before asymmetric gene
expression and ciliary flow [10,11]. While these early
mechanisms are mapped onto different embryonic archi-
tectures in a variety of ways throughout phyla [74,75],
left-sided Xnr-1 expression is a well-conserved regulator
of the situs of the heart and visceral organs [76]. Our
data on epigenetic modulation provide the first detailed
glimpse into the molecular events that allow physiologi-
cal events during very early stages to be solidified into
cascades of gene expression.
Analysis of the mouse and Xenopus Nr-1 gene has
revealed a regulatory sequence in the coding region that
is crucial for the asymmetric expression at the LPM and
that is targeted by the complex FAST/SMADS [53,77].
This asymmetric enhancer (ASE) sequence is present in
the intronic region [53]. The transcription factor FAST-1
mediates TGFb signaling, and, together with SMAD-2
and -4, has been shown to be necessary to trigger Xnr-1
asymmetric expression by binding to the Xnr-1 ASE in
the LPM [77]. However, all signaling molecules that play
a role in the asymmetric expression of Nr-1 characterized
so far are symmetrically expressed in the LPM, including
the immediate upstream player FAST-1 [77]. Thus, it
becomes crucial to understand how upstream symmetric
events taking place at the cellular levels result in reliably
asymmetric Nr-1 expression. In addition, it is known that
the right side of the embryo has an intrinsic ability to
express Xnr-1, indicating that the cells on the right side
have all machinery needed to express Xnr-1 but are nor-
mally repressed from doing so [78].
Our results show that the Xnr-1 intronic region con-
tains high levels of acetylated histone H3 and H4 and
H3K4me2 after NaB treatment (Figure 3) and this corre-
lates with absence of Xnr-1 expression. Although the
biological significance in terms of transcriptional out-
comes due to H3K4me2 is still under debate, it is
becoming clear that this epigenetic marker may prevent
aberrant gene expression or modulate transcriptional
outcomes [55]. In the context of our results, a possible
interpretation is that H3K4me2 could work as a repres-
sive marker facilitating the efficiency of inhibition by
Lefty. In normal embryos these results suggest that
HDAC could target the Xnr-1 intronic region (ASE)
early during development leading to a decrease in the
levels of acetylated histones H3 and as a consequence
preventing H2K4me2 from being deposited in this
region, making this region accessible to FAST related
proteins. By the time of Xnr-1 expression initiation, the
absence of H3K4me2 would increase the efficiency of
activation of Xnr-1 expression, which will not result in
significant noise, leading to stable expression of Xnr-1.
Future experiments addressing the balance in acetyla-
tion and methylation levels of histones between left and
right sides of the embryo will be necessary to under-
stand how the epigenetic machinery controls different
elements during LR determination besides Nr1. For
instance, the investigation of epigenetic modifications on
other left-right genes, such as Lefty and Pitx will be
important to understand how global HDAC activity
blockade changes the chromatin status and how these
changes are transduced into different states of LR genes’
activity. For example, Lefty is an inhibitor of Nr1 and
any epigenetic change on Lefty due to HDAC blockade
may also affect Nr1 expression, providing a possible
explanation on the absence of XNr-1 expression when
HDAC activity is blocked. This hypothesis is supported
by the feed-forward and feedback loop between Nr1 and
Lefty that is important to exclude Nodal from being
expressed on the right side of the embryo. Consistent
with this rationale, our data implicate HDAC activity as
important to set Nr1 expression but also suggest that
HDAC activity may target Lefty, leading to its ectopic
expression on the left side that ultimately will repress
Nr1 expression. For this reason, a comprehensive under-
standing of the epigenetic regulation of the key asym-
metric genes, and the upstream components linking the
sidedness of transcription to early physiological gradi-
ents, will be a crucial aspect of fleshing out a most fasci-
nating aspect of left-right patterning.
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Conclusions
HDAC activity is a new LR determinant controlling the
transcription of the Xnr-1 gene. Molecular-genetic and
pharmacological blockade of HDAC activity led to
deposition of epigenetic markers on the Xnr-1 gene
that was correlated with misexpression of Xnr-1 and
organ heterotaxia. The known HDAC partner Mad3 is
also a new functional LR determinant whose biological
activity during LR establishment is dependent on 5HT.
Taken together these data suggest a model in which
epigenetic machinery transduces early physiological
gradients into much later transcriptional effectors
Figure 7 HDAC activity is required during LR development. (A) In this study, we found that early HDAC activity between stages 1-7 is
important to proper set the pattern of expression of XNr-1 at stage 21. In addition, we also show that HDAC activity and Mad3 are important on
the right side of the embryo to set XNr-1’s expression and that Mad’s biological activity is dependent on 5HT. Despite HDAC and Mad3 mRNAs
present a symmetric pattern of expression, one theory is that because 5HT is asymmetrically distributed in the right blastomeres at stage 7 (red),
5HT binding on Mad3 (blue) may recruit HDAC activity (orange) to the intronic region of XNr-1 on the right of the embryo. HDAC activity, at
early developmental stages, may be important to decrease the levels of acetylation of histone H3 and H4 on the intronic region of Nr1. (B) At
stage 21, low levels of acetylation on histones (H3 and H4), set by early HDAC activity, would contribute to repress the expression of Nr1, that
will be expressed only on the left side of the embryo (blue box). V-ventral; D-dorsal; R-right; L-left.
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during establishment of consistent organ situs in verte-
brate embryogenesis.
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